content

Gerresheimer invests up to 94 million Dollar in US production facility

Gerresheimer AG, a leading provider of healthcare & beauty solutions and drug delivery systems for pharma, biotech and cosmetics, announced investments to rapidly expand...

Almac Group Announces $65M Expansion of North American Headquarters in Pennsylvania

Almac Group, the global contract development and manufacturing organisation, today announces a $65 million, 100,000 ft2expansion of clinical supply operations at the companyโ€™s North...

Sartorius to acquire Albumedix, strengthening its portfolio of innovative advanced therapy solutions

The life science group Sartorius, through its French listed subgroup Sartorius Stedim Biotech, has agreed to acquire 100 percent of Albumedix Ltd. from private...

Charles River Receives EMA Approval to Produce Allogeneic Cell Therapy

Charles River Laboratories, International Inc. announced it has received regulatory approval, in the form of Good Manufacturing Practice (GMP) certification, to commercially produce allogeneic...

WuXi Advanced Therapies Announces Licensing Agreement with Janssen

WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, announced a licensing agreement with Janssen Biotech, Inc., one of the Janssen...

Mayne Pharma Announces Sale of Metrics Contract Services for US$475 Million

Mayne Pharma Group Limited announced that it has entered into an agreement with Catalent, Inc., the global leader in enabling biopharma, cell, gene, and...

3 Viruses The Pharmaceutical Industry Needs To Prepare For

More than half of the known infectious diseases are getting worse due to climate change. Monkeypox is expanding, and recently, news of an outbreak...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read